Finance entity

Oppenheimer

Company

The clearest coverage concentration is markets: 6 of 8 stories, with the rest divided among 2 other categories. Sentiment skews less negative than the wider beat, at 0% negative against 25% across all 3457 Finance stories in the same window.

Last mentioned: 1d ago

Entity pulse

Recent coverage · Oppenheimer

↑
8 stories
5.5 avg impact
13% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 13 percentage points.

  • 13% positive
  • 88% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Oppenheimer

The clearest coverage concentration is markets: 6 of 8 stories, with the rest divided among 2 other categories. Sentiment skews less negative than the wider beat, at 0% negative against 25% across all 3457 Finance stories in the same window. Morgan Stanley is the most frequent co-covered peer, appearing in 3 of the 8 tracked stories. That works out to roughly 0.3 stories per week across a 203-day span. At 5.5, the average consequence score sits below the same-window beat average of 6.2. Source depth averages 2.4 original sources per story, versus 2.7 across the same-window beat baseline. We currently track 8 Finance stories that mention Oppenheimer, published between March 11, 2026 and September 29, 2026.

Stories tracked
8
Per week
0.3
Negative
0%
Sources per story
2.4

Computed from the 8 stories linked to this entity, with beat comparisons drawn from all 3457 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Oppenheimer. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Wells Fargo Cuts Target to $70

    Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside.

  2. Bank of America Lowers Target

    Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating.

  3. TD Cowen Sets Street-High $73 Target

    TD Cowen raised target from $63 to $73, the highest among all analysts, maintaining a Buy rating.

  4. Piper Sandler Stays Overweight

    Piper Sandler reaffirms an Overweight rating on Freshpet shares.

  5. Weiss Ratings Downgrades

    Weiss Ratings cuts Freshpet from 'Hold (c)' to 'Hold (c-)'.

  6. Morgan Stanley Revises Target to $51

    Morgan Stanley raised target from $38 to $51 but kept Equal Weight rating, signaling a cautious stance.

  7. Analyst Surge: Four Firms Raise Targets

    Oppenheimer, Goldman Sachs, KeyCorp, and Barclays all lifted price targets to the $55–$60 range, reiterating Buy/Outperform ratings.

  8. JPMorgan Upgrades, Others Reaffirm

    JPMorgan raises rating from Neutral to Overweight and lifts target from $66.00 to $68.00. Morgan Stanley reiterates Overweight with $77.00 target, while Deutsche Bank holds at Hold with $63.00 target.

  9. Jefferies Cuts Target

    Jefferies Financial Group lowers its price objective from $75.00 to $70.00 and maintains a Hold rating.

  10. TD Cowen Turns Bullish

    TD Cowen upgrades Freshpet from Hold to Buy and sets an $80.00 price objective.

  11. Oppenheimer Upgrades Freshpet

    Oppenheimer raises Freshpet from Market Perform to Outperform with an $80.00 price target.

  12. Zacks Downgrades to Hold

    Zacks Research downgraded Forgent Power Solutions to a Hold rating amid valuation concerns.

Stories mentioning Oppenheimer 8

Markets Neutral

MARA Up 4.6% at $11.83 and STRL Up 3.2%: Analyst Targets Slip

Tuesday's midday tape lifted MARA 4.6% to $11.83 and Sterling Infrastructure 3.2% to $502.20, but the more important signal for investors is a multi-week pattern of analyst price-target cuts. MARA's consensus target of $18.78 implies large upside yet carries 5.32 beta and negative earnings; STRL's $690.33 target still sits 37% above its price but below prior $900-plus targets. Finance readers should weigh consensus 'Moderate Buy' labels against balance-sheet and technical risks.

3 sources

Source: themarketsdaily.com · tickerreport.com

Oppenheimer is linked from 8 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.